滕雯迪查看源代码讨论查看历史
|
滕雯迪，女，北京工商大学讲师。
人物简历
教育经历
2009年9月至2013年6月 东北农业大学 获学士学位
2013年9月至2016年6月 北京化工大学 获硕士学位
2019年9月至2021年1月 康奈尔大学 联合培养
2016年9月至2021年7月 中国农业大学 获博士学位
工作经历
2021年9月-至今 北京工商大学食品与健康学院 讲师
主讲课程
分子营养学
研究领域
食源性物质的功能活性及作用机制
功能食品的开发与功能评价
蛋白质翻译后修饰的功能及其应用
学术成果
论文
1. Wendi Teng, Liyun Zhao, Songtao Yang, Chengying Zhang, Meiyu Liu, Jie Luo, Junhua Jin, Ming Zhang, Chen Bao, Dan Li, Yuan Li and Fazheng Ren*. The hepatic-targeted, resveratrol loaded nanoparticles for relief of high fat diet-induced nonalcoholic fatty liver disease. Journal of Controlled Release, 2019, 307:139-149;
2. Wendi Teng, Yuan Li, Min Du, Xingen Lei, Siyu Xie and Fazheng Ren*. Sulforaphane prevents hepatic insulin resistance by blocking serine palmitoyltransferase 3- mediated ceramide biosynthesis. Nutrients, 2019, 11(5): 1185;
3. Siyu Xie, Yuan Li, Wendi Teng, Min Du, Yixuan Li, Baoguo Sun*. Liensinine inhibits beige adipocytes recovering to white adipocytes through blocking mitophagy flux in vitro and in vivo. Nutrients, 2019, 11(7); 1640;
4. Wendi Teng, Wenjing Yin, Liang Zhao, Changwei Ma, Jiaqiang Huang and Fazheng Ren*. Resveratrol metabolites ameliorate insulin resistance in HepG2 hepatocytes via modulating IRS-1/ AMPK. RSC advances, 2018, 8:36034-36042;
5. Ming Yang, Wendi Teng, Yue Qu, Haiyong Wang and Qipeng Yuan*. Sulforaphene inhibits triple negative breast cancer through activating tumor suppressor Egr1. Breast Cancer Research & Treatment, 2016, 158:277-286;
6. Congcong Zuo, Huijuan Zhang, Shuang Liang, Wendi Teng, Cheng Bao, Dan Li, Yuling Hu, Qimeng Wang, Zekun Li, Yuan Li*. The alleviation of lipid deposition in steatosis hepatocytes by capsaicin-loaded α-lactalbumin nanomicelles via promoted endocytosis and synergetic multiple signaling pathways. Journal of Functional Foods, 2021, 79 (2021), 104396;
7. Ming Yang, Meng Ren, Yue Qu, Wendi Teng, Zhongpeng Wang, Hao Li and Qipeng Yuan*. Sulforaphene inhibits hepatocellular carcinoma through repressing keratin 8 and activating anoikis. RSC Advances, 2016, 6(74):70326-70334.[1]